Biotechnology is given enough importance these days because of its benefits and promising advancements in the nearest future. While there are those who stick to the old model in biotechnology collaborations, there are still those who want to give a shot for the new paradigm at hand.
The use between old models and new models of biotechnology collaborations is constantly argued about. When the old paradigm was still reigning, there was a need for easy access to the sales forces of big pharmaceutical companies that are already established in order to gain success in the commercial world. However, a major change has set the new paradigm into being. Due to the mass layoffs of big pharmaceutical companies, there is now an excess in the number of trained and skilled sales representatives.